Bill Sponsor
House Bill 1046
116th Congress(2019-2020)
Medicare Negotiation and Competitive Licensing Act of 2019
Introduced
Introduced
Introduced in House on Feb 7, 2019
Overview
Text
Introduced
Feb 7, 2019
Latest Action
Sep 25, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
1046
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Texas
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
Colorado
Democrat
Colorado
Democrat
Connecticut
Democrat
Connecticut
Democrat
Connecticut
Democrat
District of Columbia
Democrat
Florida
Democrat
Georgia
Democrat
Hawaii
Democrat
Illinois
Democrat
Illinois
Democrat
Kentucky
Democrat
Maryland
Democrat
Massachusetts
Democrat
Massachusetts
Democrat
Michigan
Democrat
Minnesota
Democrat
Minnesota
Democrat
Mississippi
Democrat
Nevada
Democrat
New Hampshire
Democrat
New Jersey
Democrat
New Jersey
Democrat
New Mexico
Democrat
New York
Democrat
New York
Democrat
New York
Democrat
New York
Democrat
North Carolina
Democrat
North Carolina
Democrat
Pennsylvania
Democrat
Pennsylvania
Democrat
Pennsylvania
Democrat
Pennsylvania
Democrat
Pennsylvania
Democrat
Rhode Island
Democrat
Rhode Island
Democrat
Tennessee
Democrat
Virginia
Democrat
Virginia
Democrat
Virginia
Democrat
Washington
Democrat
Wisconsin
Democrat
Wisconsin
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Medicare Negotiation and Competitive Licensing Act of 2019

This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. (Current law prohibits the CMS from doing so.)

The CMS must take certain factors into account during negotiations, including the clinical- and cost-effectiveness of the drug, the financial burden on patients, and unmet patient needs. If the CMS is unable to negotiate the price of a drug, such drug is subject to competitive licensing in order to further its sale under Medicare, notwithstanding existing government-granted exclusivities.

Additionally, for one year after a drug is provided under a competitive license, such drug is also subject to specified price limitations; if the drug is not offered at such prices, the drug is subject to additional licensing that furthers its sale under any federal program (e.g., Medicaid).

Text (1)
February 7, 2019
Actions (5)
09/25/2019
Subcommittee Hearings Held.
02/08/2019
Referred to the Subcommittee on Health.
02/07/2019
Referred to the Subcommittee on Health.
02/07/2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
02/07/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 3:47:47 PM